Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
7.27
+0.06 (0.83%)
At close: Oct 8, 2025, 4:00 PM EDT
7.27
0.00 (0.00%)
After-hours: Oct 8, 2025, 6:30 PM EDT
Nasus Pharma Market Cap
Nasus Pharma has a market cap or net worth of $65.86 million as of October 8, 2025.
Market Cap
65.86M
Enterprise Value
67.38M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.27
Market Cap Chart
Since the IPO on August 14, 2025, Nasus Pharma's market cap has decreased from $72.08M to $65.86M, a decrease of -8.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 65.32M | 2.27% |
Oct 6, 2025 | 63.87M | 3.52% |
Oct 3, 2025 | 61.70M | 9.13% |
Oct 2, 2025 | 56.53M | 4.00% |
Oct 1, 2025 | 54.36M | -9.77% |
Sep 30, 2025 | 60.25M | -11.92% |
Sep 29, 2025 | 68.40M | -5.63% |
Sep 26, 2025 | 72.48M | -0.62% |
Sep 25, 2025 | 72.93M | 0.63% |
Sep 24, 2025 | 72.48M | -0.12% |
Sep 23, 2025 | 72.57M | 0.13% |
Sep 22, 2025 | 72.48M | -0.16% |
Sep 18, 2025 | 72.59M | -1.38% |
Sep 17, 2025 | 73.61M | -0.06% |
Sep 16, 2025 | 73.65M | 0.74% |
Sep 12, 2025 | 73.11M | -0.86% |
Sep 11, 2025 | 73.75M | 1.88% |
Sep 10, 2025 | 72.39M | -0.14% |
Sep 9, 2025 | 72.49M | -0.11% |
Sep 8, 2025 | 72.57M | 0.38% |
Sep 5, 2025 | 72.30M | -0.38% |
Sep 4, 2025 | 72.57M | -0.86% |
Sep 3, 2025 | 73.20M | 0.50% |
Sep 2, 2025 | 72.84M | -0.74% |
Aug 29, 2025 | 73.38M | 0.62% |
Aug 28, 2025 | 72.93M | -0.12% |
Aug 27, 2025 | 73.02M | 0.37% |
Aug 26, 2025 | 72.75M | 0.50% |
Aug 25, 2025 | 72.39M | -1.96% |
Aug 22, 2025 | 73.84M | -4.12% |
Aug 21, 2025 | 77.01M | 2.41% |
Aug 20, 2025 | 75.19M | -4.49% |
Aug 19, 2025 | 78.73M | 1.16% |
Aug 18, 2025 | 77.82M | 6.05% |
Aug 15, 2025 | 73.38M | 1.81% |
Aug 14, 2025 | 72.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 765.16B |
Johnson & Johnson | 454.89B |
AbbVie | 408.01B |
UnitedHealth Group | 338.41B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 231.64B |